Phase 4 HIV trials recruiting now
30
Phase 4 recruiting
Other phases for HIV
Phase 4 HIV trials
- 2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial
- A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV
- A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments
- Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use
- Change in Body Weight and BMI in PWH with DOR/3TC/TDF Compared with INSTI
- Doravirine Dose Optimisation in Pregnancy
- Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir Alafenamide/Emtricitabine in Virologically Suppressed People Living With HIV at 24 and 48 Weeks of Follow-up
- Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabine in Virologically Suppressed HIV-1-positive Individuals in Mexico
- Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up
- Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
- HIV Prevention With PrEP Among People on Opioid Replacement Therapy
- HIV Prevention and Care Interventions for Youth in Uganda
- Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals
- Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV
- Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women
- Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs
- Low Dose Naltrexone for Pain in Patients With HIV
- Menopausal HT for Women Living With HIV (HoT)
- Multi-product PrEP Delivery to Young Women Seeking Reproductive Health Services and Coverage of HIV Prevention
- OPTImizing Malaria And HIV Treatment in a Shifting Landscape in Africa
- Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP
- Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial
- REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE
- Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV
- Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience
- Switch to Dolutegravir Plus Lamivudine Dual-Therapy in Transgender Women Living With HIV on Virologically Suppressive Antiretroviral Therapy (TRANS-SWITCH)
- UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study
- Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
- Vaccine Immunity and Inflammation in the Aging Person Living With HIV
- Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Individuals
Common questions
What does Phase 4 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.